{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:12:29Z","timestamp":1790694749732,"version":"4.1.0"},"reference-count":0,"publisher":"Kare Publishing","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anatol J Cardiol"],"DOI":"10.14744\/anatoljcardiol.2024.2736","type":"journal-article","created":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T07:02:10Z","timestamp":1714374130000},"page":"229-235","source":"Crossref","is-referenced-by-count":6,"title":["The Effect of Empagliflozin on Janus Kinase 2\/Signal Transducer and Activator of Transcription 3 Pathway in Patients with Type 2 Cardiorenal Syndrome"],"prefix":"10.14744","author":[{"given":"Pei","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5966","published-online":{"date-parts":[[2024]]},"container-title":["The Anatolian Journal of Cardiology"],"original-title":[],"link":[{"URL":"https:\/\/jag.journalagent.com\/anatoljcardiol\/pdfs\/AJC_28_5_229_235.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T08:32:26Z","timestamp":1722241946000},"score":1,"resource":{"primary":{"URL":"https:\/\/anatoljcardiol.com\/article\/AJC-60886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":0,"URL":"https:\/\/doi.org\/10.14744\/anatoljcardiol.2024.2736","relation":{},"ISSN":["2149-2263"],"issn-type":[{"value":"2149-2263","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]}}}